Contribution of gender and body fat distribution to inflammatory marker concentrations in apparently healthy young adults

Inflammation Research

Volumn 61, Issue 5, 2012, Pages 427-435

  Hermsdorff, Helen Hermana M ^a   Volp, Ana Carolina P ^b   Puchau, Blanca ^a   Barbosa, Kiriaque B F ^c   Zulet, M Ángeles ^a   Bressan, Josefina ^d   Martínez, J Alfredo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^c FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^d FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Body fat distribution; C reactive protein; Ceruloplasmin; Complement C3; Gender; Humans

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; COMPLEMENT COMPONENT C3;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFLAMMATION; LIFESTYLE; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; BIOLOGICAL MARKERS; BODY FAT DISTRIBUTION; C-REACTIVE PROTEIN; CERULOPLASMIN; COMPLEMENT C3; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; SEX FACTORS; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84863104191     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0429-z     Document Type: Article

References (49)

1. Moreno-Aliaga MJ, Campión J, Milagro FI, Berjón A, Martínez JA. Adiposity and proinflammatory state: the chicken or the egg. Adipocytes. 2005;1:1-16.
2. Volp AC, Alfenas Rde C, Costa NM, Minim VP, Stringueta PC, Bressan J. Inflammation biomarkers capacity in predicting the metabolic syndrome. Arq Bras Endocrinol Metabol. 2008;52: 537-49.
3. Zulet MA, Puchau B, Navarro C, Marti A, Martínez JA. Inflammatory biomarkers: the link between obesity and associated pathologies. Nutr Hosp. 2007;22:511-27.
4. Engström G, Hedblad B, Eriksson KF, Janzon L, Lindgarde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes. 2005;54:570-5.
5. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25:1407-15.
6. Kim OY, Shin MJ, Moon J, Chung JH. Plasma ceruloplasmin as a biomarker for obesity: a proteomic approach. Clin Biochem. 2011;44:351-6.
7. Puchau B, Zulet MA, González de Echavarri A, Navarro-Blasco I, Martínez JA. Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults. Eur J Clin Nutr. 2009;63:858-64.
8. Choi EY, Park EH, Cheong YS, Rheem I, Park SG, Yoo S. Association of C-reactive protein with the metabolic risk factors among young and middle-aged Koreans. Metabolism. 2006;55: 415-21.
9. Engström G, Hedblad B, Tyden P, Lindgarde F. Inflammationsensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study. Atherosclerosis. 2009;202:617-22.
10. Wang B, Li Q, Jiang Y, Liu Z, Zhong L, Luo R, et al. Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese. Inflamm Res. 2011;60:63-8.
11. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med. 1990;7:147-59.
12. Eder K, Baffy N, Falus A, Fulop AK. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009;58: 727-36.
13. Hermsdorff HHM, Puchau B, Zulet MA, Martínez JA. Association of body fat distribution with proinflammatory gene expression in peripheral blood mononuclear cells from young adult subjects. OMICS. 2010;14:297-307.
14. Hermsdorff HHM, Zulet MA, Puchau B, Martínez JA. Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation. 2011;34:161-70.
15. Lapice E, Maione S, Patti L, Cipriano P, Rivellese AA, Riccardi G, et al. Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people. Diabetes Care. 2009;32:1734-6.
16. Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: the effects of weight loss. Nutr Res Rev. 2008; 21:117-33.
17. Hermsdorff HHM, Zulet MA, Bressan J, Martínez-González MA, Martínez JA. Impact of caloric restriction and Mediterranean food-based diets on inflammation accompanying obesity and metabolic syndrome features. Obes Metab. 2009;5:69-77.
18. Vague J. Sexual differentiation. A determinant factor of the forms of obesity. 1947. Obes Res. 1996;4:201-3.
19. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Després JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr. 1993;58: 463-7.
20. Cartier A, Cote M, Lemieux I, Perusse L, Tremblay A, Bouchard C, et al. Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr. 2009;89: 1307-14.
21. Leung J, Jayachandran M, Kendall-Thomas J, Behrenbeck T, Araoz P, Miller VM. Pilot study of sex differences in chemokine/cytokine markers of atherosclerosis in humans. Gend Med. 2008;5:44-52.
22. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich- Horvat P, Larson MG, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007;116:1234-41.
23. Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study. Diabet Med. 2008;25:747-50.
24. Hermsdorff HHM, Zulet MA, Puchau B, Bressan J, Martínez JA. Association of retinol-binding protein-4 with dietary selenium intake and other lifestyle features in young healthy women. Nutrition. 2009;25:392-9.
25. Pérez S, Parra MD, Martínez de Morentin B, Rodríguez MC, Martínez JA. Evaluación de la variabilidad intraindividual de la medida de composición corporal mediante bioimpedancia en voluntarias sanas y su relación con el índice de masa corporal y el pliegue tricipital. Enferm Clin. 2005;15:307-14.
26. World Health Organization (WHO). Programme of nutrition, family and reproductive health. obesity. Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, 1997. 1998.
27. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32:77-97.
28. Siri WE. The gross composition of the body. Adv Biol Med Phys. 1956;4:239-80.
29. Whitworth JA, Chalmers J. World health organisation-international society of hypertension (WHO/ISH) hypertension guidelines. Clin Exp Hypertens. 2004;26:747-52.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
31. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 1988; 4 SUPPL. A:5A-10A.
32. Willett WC. Nutritional epidemiology. New York: Oxford University Press; 1998.
33. Hermsdorff HHM, Monteiro JB. Visceral, subcutaneous or intramuscular fat: where is the problem? Arq Bras Endocrinol Metabol. 2004;48:803-11.
34. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-80.
35. Hermsdorff HHM, Zulet MA, Abete I, Martínez JA. Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects. Endocrine. 2009;36:445-51.
36. Hermsdorff HHM, Zulet MA, Abete I, Martínez JA. A legumebased hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects. Eur J Nutr. 2011;50:61-9.
37. Lee IS, Shin G, Choue R. A 12-week regimen of caloric restriction improves levels of adipokines and pro-inflammatory cytokines in Korean women with BMIs greater than 23 kg/m2. Inflamm Res. 2010;59:399-405.
38. Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K. Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men. Cardiovasc Diabetol. 2007;6:27.
39. Santos AC, Lopes C, Guimaraes JT, Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes (Lond). 2005;29: 1452-6.
40. Cignarelli M, DePergola G, Picca G, Sciaraffia M, Pannacciulli N, Tarallo M, et al. Relationship of obesity and body fat distribution with ceruloplasmin serum levels. Int J Obes Relat Metab Disord. 1996;20:809-13.
41. Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM, et al. Sex differences in the relationship between C-reactive protein and body fat. J Clin Endocrinol Metab. 2009;94:3251-8.
42. Després JP, Allard C, Tremblay A, Talbot J, Bouchard C. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism. 1985;34: 967-73.
43. Onat A, Hergenc G, Can G, Kaya Z, Yuksel H. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population. Metabolism. 2009;59:628-34.
44. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007; 4 SUPPL. B:S162-S177.
45. Saltevo J, Kautiainen H, Vanhala M. Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes. Gend Med. 2009;6:463-70.
46. Johnson PE, Milne DB, Lykken GI. Effects of age and sex on copper absorption, biological half-life, and status in humans. Am J Clin Nutr. 1992;56:917-25.
47. Wener MH, Daum PR, McQuillan GM. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol. 2000;27:2351-9.
48. Garmizo G, Frauens BJ. Corneal copper deposition secondary to oral contraceptives. Optom Vis Sci. 2008;85:802-7.
49. van Rooijen M, Hansson LO, Frostegard J, Silveira A, Hamsten A, Bremme K. Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response. J Thromb Haemost. 2006;4: 77-82.